Home
>
National Drug Code (NDC)
>
Zanaflex
Zanaflex - 10144-606-15 - (tizanidine hydrochloride)
Drug Information of Zanaflex
| Product NDC: | 10144-606 |
| Proprietary Name: | Zanaflex |
| Non Proprietary Name: | tizanidine hydrochloride |
| Active Ingredient(s): | 6 mg/1 & nbsp; tizanidine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zanaflex
| Product NDC: | 10144-606 |
| Labeler Name: | Acorda Therapeutics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021447 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050404 |
Package Information of Zanaflex
| Package NDC: | 10144-606-15 |
| Package Description: | 150 CAPSULE in 1 BOTTLE (10144-606-15) |
NDC Information of Zanaflex
| NDC Code | 10144-606-15 |
| Proprietary Name | Zanaflex |
| Package Description | 150 CAPSULE in 1 BOTTLE (10144-606-15) |
| Product NDC | 10144-606 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tizanidine hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20050404 |
| Marketing Category Name | NDA |
| Labeler Name | Acorda Therapeutics, Inc. |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Strength Number | 6 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
